Key Competitors - Non-Small Cell Lung Cancer Industry

The expansion of the market is anticipated to be driven by the approval of an increasing number of innovative drugs for the treatment of non-small cell lung cancer. For example, in the month of August 2019, Roche Holding, which is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics, received the approval for Rozlytrek (entrectinib) from the U.S. Food and Drug Administration (FDA). This medication is indicated for the treatment of adults who have ROS1-positive, metastatic non-small cell lung cancer.

Global Non-small cell lung cancer treatment market is estimated to be valued at US$ 24,910.7 million in 2022 and is expected to exhibit a CAGR of 9.4% during the forecast period (2022-2030).

Market Players in the Non-Small Cell Lung Cancer Industry:

1. Pfizer Inc

Pfizer Inc. was launch in 1849. And its headquarter - New York, New York, United States. It operate over 40 country

2. AstraZeneca plc,

AstraZeneca plc, founded in 1999, and it’s located in Cambridge, United Kingdom. The company operates in 108 countries. In 2020 AstraZeneca has entered a commercialisation agreement with Daiichi Sankyo Company for potential new therapeutic for the treatment

3. F. Hoffmann-La Roche Ltd

F. Hoffmann-La Roche Ltdy was launch in 1896 and it’s headquarter located in Basel, Switzerland.it operate over 20 country .In2022 Fulcrum BioEnergy Announces Major Strategic Investment by bp. Fulcrum and bp partnership accelerates Fulcrum's large program of waste-to-jet fuel plants.

4 Eli Lilly and Company,

Eli Lilly and Company,, was launch in 1876 and it’s headquarter located in Indianapolis, Indiana, United States.it operate over 18 country

5. Boehringer Ingelheim GMBH

Boehringer Ingelheim GMBH founded in 1885, with its headquarters in Ingelheim am Rhein, Germany.With businesses in over 108 countries.

6 Novartis AG,

Novartis AG,s ,was launch 1996 and its headquarter Breda Basel, Switzerland‎.it operate over 140 country.

7. Bristol-Myers Squibb Company

Bristol-Myers Squibb Company founded in 1887, with its headquarters in New York, New York, United States. With businesses in over 108 countries.

*Definition-

Non-small cell lung cancer is a group of lung cancers that behave similarly, such as squamous cell carcinoma and adenocarcinoma..